Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alzchem is a leading international specialty chemical company headquartered in Trostberg, Germany, and is the sole manufacturer of Creapure, a premium brand of creatine monohydrate. The company operates a vertically integrated production process, ensuring high purity and safety standards through dedicated GMP-certified facilities. Alzchem's health and nutrition division focuses on the development and supply of high-quality nutritional supplements for sports, healthy aging, and medical applications. Beyond its flagship creatine product, the company provides a diverse range of chemical solutions for the pharmaceutical, agricultural, and automotive industries. Alzchem is publicly traded on the Frankfurt Stock Exchange and maintains a strong global presence through its extensive distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Creapure.